351 related articles for article (PubMed ID: 20040915)
1. Non-alcoholic fatty liver disease in liver transplant recipients: another story of "seed and soil".
Dumortier J; Giostra E; Belbouab S; Morard I; Guillaud O; Spahr L; Boillot O; Rubbia-Brandt L; Scoazec JY; Hadengue A
Am J Gastroenterol; 2010 Mar; 105(3):613-20. PubMed ID: 20040915
[TBL] [Abstract][Full Text] [Related]
2. Non-alcoholic fatty liver disease after liver transplantation: a case of nurture and nature.
Ong J; Younossi ZM
Am J Gastroenterol; 2010 Mar; 105(3):621-3. PubMed ID: 20203643
[TBL] [Abstract][Full Text] [Related]
3. Histologically proven non-alcoholic fatty liver disease and clinically related factors in recipients after liver transplantation.
Kim H; Lee K; Lee KW; Yi NJ; Lee HW; Hong G; Choi Y; You T; Suh SW; Jang JJ; Suh KS
Clin Transplant; 2014 May; 28(5):521-9. PubMed ID: 24579874
[TBL] [Abstract][Full Text] [Related]
4. Non-alcoholic steatohepatitis in children.
Nanda K
Pediatr Transplant; 2004 Dec; 8(6):613-8. PubMed ID: 15598336
[TBL] [Abstract][Full Text] [Related]
5. Development of nonalcoholic fatty liver disease after orthotopic liver transplantation for cryptogenic cirrhosis.
Contos MJ; Cales W; Sterling RK; Luketic VA; Shiffman ML; Mills AS; Fisher RA; Ham J; Sanyal AJ
Liver Transpl; 2001 Apr; 7(4):363-73. PubMed ID: 11303298
[TBL] [Abstract][Full Text] [Related]
6. Allograft steatohepatitis in progressive familial intrahepatic cholestasis type 1 after living donor liver transplantation.
Miyagawa-Hayashino A; Egawa H; Yorifuji T; Hasegawa M; Haga H; Tsuruyama T; Wen MC; Sumazaki R; Manabe T; Uemoto S
Liver Transpl; 2009 Jun; 15(6):610-8. PubMed ID: 19479804
[TBL] [Abstract][Full Text] [Related]
7. Nonalcoholic fatty liver disease after liver transplantation for cryptogenic cirrhosis or nonalcoholic fatty liver disease.
Yalamanchili K; Saadeh S; Klintmalm GB; Jennings LW; Davis GL
Liver Transpl; 2010 Apr; 16(4):431-9. PubMed ID: 20373454
[TBL] [Abstract][Full Text] [Related]
8. Negative impact of de novo malignancies rather than alcohol relapse on survival after liver transplantation for alcoholic cirrhosis: a retrospective analysis of 305 patients in a single center.
Dumortier J; Guillaud O; Adham M; Boucaud C; Delafosse B; Bouffard Y; Paliard P; Scoazec JY; Boillot O
Am J Gastroenterol; 2007 May; 102(5):1032-41. PubMed ID: 17313502
[TBL] [Abstract][Full Text] [Related]
9. Post-transplant diabetes mellitus in liver transplantation: Hangzhou experience.
Xu X; Ling Q; He ZL; Gao F; Zheng SS
Hepatobiliary Pancreat Dis Int; 2008 Oct; 7(5):465-70. PubMed ID: 18842490
[TBL] [Abstract][Full Text] [Related]
10. Impact of donor graft steatosis on overall outcome and viral recurrence after liver transplantation for hepatitis C virus cirrhosis.
Briceño J; Ciria R; Pleguezuelo M; de la Mata M; Muntané J; Naranjo A; Sánchez-Hidalgo J; Marchal T; Rufián S; López-Cillero P
Liver Transpl; 2009 Jan; 15(1):37-48. PubMed ID: 19109846
[TBL] [Abstract][Full Text] [Related]
11. Delayed onset of severe hepatitis C-related liver damage following liver transplantation: a matter of concern?
Berenguer M; Aguilera V; Prieto M; Carrasco D; Rayón M; San Juan F; Landaverde C; Mir J; Berenguer J
Liver Transpl; 2003 Nov; 9(11):1152-8. PubMed ID: 14586875
[TBL] [Abstract][Full Text] [Related]
12. Prevalence and clinical associations of posttransplant fatty liver disease.
Lim LG; Cheng CL; Wee A; Lim SG; Lee YM; Sutedja DS; Da Costa M; Prabhakaran K; Wai CT
Liver Int; 2007 Feb; 27(1):76-80. PubMed ID: 17241384
[TBL] [Abstract][Full Text] [Related]
13. Prevalence and risk factors of non-alcoholic fatty liver disease in potential living liver donors in Korea: a review of 589 consecutive liver biopsies in a single center.
Lee JY; Kim KM; Lee SG; Yu E; Lim YS; Lee HC; Chung YH; Lee YS; Suh DJ
J Hepatol; 2007 Aug; 47(2):239-44. PubMed ID: 17400323
[TBL] [Abstract][Full Text] [Related]
14. Factors influencing renal function after liver transplantation. Results from the MOST, an international observational study.
Burra P; Senzolo M; Masier A; Prestele H; Jones R; Samuel D; Villamil F
Dig Liver Dis; 2009 May; 41(5):350-6. PubMed ID: 19046932
[TBL] [Abstract][Full Text] [Related]
15. Cryptogenic cirrhosis: clinicopathologic findings at and after liver transplantation.
Ayata G; Gordon FD; Lewis WD; Pomfret E; Pomposelli JJ; Jenkins RL; Khettry U
Hum Pathol; 2002 Nov; 33(11):1098-104. PubMed ID: 12454814
[TBL] [Abstract][Full Text] [Related]
16. The natural history of nonalcoholic fatty liver disease: a clinical histopathological study.
Harrison SA; Torgerson S; Hayashi PH
Am J Gastroenterol; 2003 Sep; 98(9):2042-7. PubMed ID: 14499785
[TBL] [Abstract][Full Text] [Related]
17. [Steatosis and nonalcoholic steatohepatitis. A comparative analysis].
Piñol V; Bessa X; Bruguera M; Rodés J
Gastroenterol Hepatol; 2000 Feb; 23(2):57-61. PubMed ID: 10726383
[TBL] [Abstract][Full Text] [Related]
18. A simple score for predicting alcohol relapse after liver transplantation: results from 387 patients over 15 years.
De Gottardi A; Spahr L; Gelez P; Morard I; Mentha G; Guillaud O; Majno P; Morel P; Hadengue A; Paliard P; Scoazec JY; Boillot O; Giostra E; Dumortier J
Arch Intern Med; 2007 Jun; 167(11):1183-8. PubMed ID: 17563028
[TBL] [Abstract][Full Text] [Related]
19. Hepatic histopathology of morbid obesity: concurrence of other forms of chronic liver disease.
Liew PL; Lee WJ; Lee YC; Wang HH; Wang W; Lin YC
Obes Surg; 2006 Dec; 16(12):1584-93. PubMed ID: 17217634
[TBL] [Abstract][Full Text] [Related]
20. Recurrent disease following liver transplantation for nonalcoholic steatohepatitis cirrhosis.
Malik SM; Devera ME; Fontes P; Shaikh O; Sasatomi E; Ahmad J
Liver Transpl; 2009 Dec; 15(12):1843-51. PubMed ID: 19938117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
